Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Immunometabolic Effects of Intermittent Fasting During Immune Checkpoint Inhibitor Therapy: A Randomized Pilot Study in Advanced Solid Tumors

NCT07645742 is registered in ClinicalTrials.gov with West Virginia University as lead sponsor.

NCT NCT07645742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07645742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Immunometabolic Effects of Intermittent Fasting During Immune Checkpoint Inhibitor Therapy: A Randomized Pilot Study in Advanced Solid Tumors
Lead sponsor
West Virginia University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
February 28, 2029
Enrollment
90 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer (advanced stage)